The Dark Side of Pharmaceutical Company Relationships with Physicians

As an exhausted and overworked medical student, I received a stream of gifts from pharmaceutical representatives, including expensive pens and textbook sets, which left me wondering about the nature of this relationship. My friend's comment that it's "behavioral science at its most basic" sparked a reevaluation of this dynamic, revealing that both physicians and pharmaceutical companies have been reinforcing each other's behavior through rewards and positive interactions. This cycle of mutual reinforcement highlights the need for a reassessment of the relationship between the two parties.

Key Takeaways:

• The relationship between physicians and pharmaceutical companies is built on a cycle of mutual reinforcement, with rewards and positive interactions driving behavior.
• This dynamic is rooted in behavioral science, where individuals are more likely to repeat behaviors that result in rewards.
• Physicians, including the author, have received gifts and favors from pharmaceutical companies, including expensive pens, textbook sets, and samples of medications.
• These gifts and favors can create a sense of obligation and gratitude in physicians, influencing their prescribing decisions and relationships with pharmaceutical companies.
• The author's experience with a patient who required medication but couldn't afford it highlights the need for pharmaceutical companies to provide easier access to their products for underinsured or uninsured patients.
• Direct contact with pharmaceutical companies can result in adequate supplies of medications, and positive follow-ups can ensure that companies respond to physician requests.
• The author's experience with a $150 pen emblazoned with their name in gold highlights the excesses of this relationship and the need for a more balanced approach.

Statistics:

• The author received a textbook set worth over $100 from a pharmaceutical representative during their medical school days.
• The same representative provided the author with a year's supply of medication for a patient who couldn't afford it, after a series of positive interactions and a written request.
• The author Estimated that they had received "small samples" of drugs from pharmaceutical companies due to their interactions.

Sources:

• "The Dark Side of Pharmaceutical Company Relationships with Physicians" by Dr. Atkins, published in a medical journal (no specific publication date or title given).
• "The Portrait" by Dr. Atkins, a murder mystery novel scheduled for spring release by St. Martin Press.
• Letter to the editor from Dr. Atkins, detailing their experience with a patient who required medication but couldn't afford it and the subsequent response from the pharmaceutical company.